// App-Quantinova.ai

[THU0106] : IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE, DOES BODY MASS INDEX INFLUENCE THE EFFICACY OF ABATACEPT ON INFLAMMATION WHEN MEASURED BY POWER DOPPLER ULTRASONOGRAPHY? RESULTS FROM THE APPRAISE STUDY

Researchers

Presenter

  • M.A. -Agostino

Principal Investigators

  • M. Le Bars

  • M. Taylor

  • B. Chou

  • J. Zhu

  • V.K. Ranganath

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Bristol-Myers Squibb

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Obesity

  • Inflammatory Arthritis

Biomarkers

  • C reactive protein

  • Fibrillin-1

  • High sensitivity C-reactive protein

  • Body mass index

Drug/Treatment

  • Methotrexate

  • Abatacept

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim